Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis

Area of Science:

• Genetics
• Genomic Stability
• Cancer Biology

Background:

• The MBD4 gene is crucial for maintaining genomic stability at CpG sites.
• MBD4 mutations are common in mismatch repair (MMR)-defective colorectal tumors (CRC), but its precise role in tumorigenesis is debated.
• Conflicting results from Mbd4-deficient mouse models necessitate further investigation into MBD4's functional impact.

Purpose of the Study:

• To investigate the role of MBD4 variants in hereditary/familial and sporadic colorectal cancer (CRC).
• To determine if MBD4 alterations contribute to the mutator phenotype independently of mismatch repair (MMR) defects.
• To clarify whether MBD4 mutations are secondary to MMR defects or have independent functional consequences in tumorigenesis.

Main Methods:

• Analysis of MBD4 variants (frameshift and missense) in a large cohort of CRC cases (hereditary, familial, sporadic).
• Comparison of MBD4 variant presence in tumor DNA versus normal DNA.
• Assessment of transition mutation frequency in CRC with single or double MBD4/MMR variants.
• Evaluation of Mbd4-deficient mice survival in combination with Mlh1-/- genotype.

Main Results:

• MBD4 frameshift variants were exclusively found in tumors, while missense variants occurred in both tumor and normal DNA.
• Increased transition mutation frequency was observed in CRC cases with MBD4 variants, irrespective of MMR status.
• Mbd4-deficient mice exhibited reduced survival when combined with an Mlh1-/- genotype, suggesting a synergistic effect.

Conclusions:

• MBD4 inactivation can contribute to colorectal cancer (CRC) development.
• MBD4 defects may independently influence the mutational landscape, acting as a modifier of the MMR-deficient cancer phenotype.
• MBD4 alterations are not merely secondary to MMR defects but can actively promote tumorigenesis.